NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said today that it will raise $300 million through the sale of senior notes through a private offering.

The $300 million, which the company plans to use for general corporate purposes, working capital, and potentially for acquisitions, is an increase of $50 million over what the company said on Monday that it planned to receive from the sale.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.